美国 · SEC FORM 4
PFIZER INC
PFE · NYSE · CIK 0000078003 · Healthcare · Drug Manufacturers—General
内部人信号
3 位买方 · 3 条买入交易行 · $3.0M 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：Chairman & CEO（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chairman & CEO, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 67.9
- 67.8
- 67.8
- 67.7
- 67.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +2.3%
- 3M
- +15.5%
- 6M
- +5.1%
- 12M
- +10.1%
波动率与流动性
- 波动率
- 24.2%
- Beta
- —
- 平均每日成交额
- USD 1.0B
估值
- 市值
- USD 161.2B
- P/E
- 20.7×
基本面
- 利润率
- 12.4%
- ROE
- 9.0%
- 细分行业
- Drug Manufacturers—General
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, P/E, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-29 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 150,217,617
- 上期报告
- 155,202,257
- 日均成交量
- 34,031,762
- 回补天数
- 4.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | BOURLA ALBERT | 买入 (P) | Common Stock | 38,000 | USD 26.34 | USD 1,000,920 | SEC 申报 ↗ |
| 2026-08-05 | Buckley Mortimer J | 买入 (P) | Common Stock | 37,632 | USD 25.52 | USD 960,369 | SEC 申报 ↗ |
| 2026-08-05 | BLAYLOCK RONALD E | 买入 (P) | Common Stock | 39,231 | USD 25.46 | USD 998,821 | SEC 申报 ↗ |
| 2025-02-13 | BLAYLOCK RONALD E | 买入 (P) | Common Stock | 19,457 | USD 25.65 | USD 499,072 | SEC 申报 ↗ |
| 2024-10-30 | Gottlieb Scott | 买入 (P) | Common Stock | 1,000 | USD 28.24 | USD 28,240 | SEC 申报 ↗ |
| 2023-12-15 | Gottlieb Scott | 买入 (P) | Common Stock | 3,000 | USD 26.47 | USD 79,410 | SEC 申报 ↗ |
| 2023-05-08 | Gottlieb Scott | 买入 (P) | Common Stock | 1,000 | USD 38.58 | USD 38,580 | SEC 申报 ↗ |
| 2023-05-05 | Gottlieb Scott | 买入 (P) | Common Stock | 1,000 | USD 38.43 | USD 38,430 | SEC 申报 ↗ |
| 2020-08-06 | BLAYLOCK RONALD E | 买入 (P) | Common Stock | 13,000 | USD 38.55 | USD 501,085 | SEC 申报 ↗ |
| 2020-01-30 | Gottlieb Scott | 买入 (P) | Common Stock | 1,000 | USD 37.00 | USD 37,000 | SEC 申报 ↗ |
Form 4 申报证据
33 transaction lines in the latest 365-day window; 527 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | BOURLA ALBERT | 买入 (P) | Common Stock | 38,000 | USD 26.34 | USD 1,000,920 | SEC 申报 ↗ |
| 2026-08-05 | DAMICO JENNIFER B. | 卖出 (S) | Common Stock | 3,278 | USD 25.40 | USD 83,261 | SEC 申报 ↗ |
| 2026-08-05 | Buckley Mortimer J | 买入 (P) | Common Stock | 37,632 | USD 25.52 | USD 960,369 | SEC 申报 ↗ |
展开近期 Form 4 证据 (26 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | BOURLA ALBERT | 买入 (P) | Common Stock | 38,000 | USD 26.34 | USD 1,000,920 | SEC 申报 ↗ |
| 2026-08-05 | DAMICO JENNIFER B. | 卖出 (S) | Common Stock | 3,278 | USD 25.40 | USD 83,261 | SEC 申报 ↗ |
| 2026-08-05 | Buckley Mortimer J | 买入 (P) | Common Stock | 37,632 | USD 25.52 | USD 960,369 | SEC 申报 ↗ |
| 2026-08-05 | BLAYLOCK RONALD E | 买入 (P) | Common Stock | 39,231 | USD 25.46 | USD 998,821 | SEC 申报 ↗ |
| 2026-06-09 | DAMICO JENNIFER B. | 卖出 (S) | Common Stock | 2,000 | USD 25.70 | USD 51,400 | SEC 申报 ↗ |
| 2026-03-04 | DAMICO JENNIFER B. | 代扣税 (F) | Common Stock | 826 | USD 26.62 | USD 21,988 | SEC 申报 ↗ |
| 2026-03-03 | DAMICO JENNIFER B. | 奖励／授予 (A) | Common Stock | 21,719 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-27 | DAMICO JENNIFER B. | 代扣税 (F) | Common Stock | 655 | USD 27.65 | USD 18,111 | SEC 申报 ↗ |
| 2026-02-26 | McDermott Michael | 代扣税 (F) | Common Stock | 3,503 | USD 27.10 | USD 94,931 | SEC 申报 ↗ |
| 2026-02-25 | SAHNI PAYAL | 期权行权／转换 (M) | Common Stock | 56,888 | USD 33.82 | USD 1,923,952 | SEC 申报 ↗ |
| 2026-02-25 | SAHNI PAYAL | 代扣税 (F) | Common Stock | 55,149 | USD 26.92 | USD 1,484,795 | SEC 申报 ↗ |
| 2026-02-25 | McDermott Michael | 期权行权／转换 (M) | Common Stock | 37,925 | USD 33.82 | USD 1,282,624 | SEC 申报 ↗ |
| 2026-02-25 | McDermott Michael | 代扣税 (F) | Common Stock | 36,723 | USD 26.92 | USD 988,699 | SEC 申报 ↗ |
| 2026-02-25 | LANKLER DOUGLAS M | 期权行权／转换 (M) | Common Stock | 122,907 | USD 33.82 | USD 4,156,715 | SEC 申报 ↗ |
| 2026-02-25 | LANKLER DOUGLAS M | 代扣税 (F) | Common Stock | 119,009 | USD 26.92 | USD 3,204,096 | SEC 申报 ↗ |
| 2026-02-25 | Fonseca Lidia | 期权行权／转换 (M) | Common Stock | 56,888 | USD 33.82 | USD 1,923,952 | SEC 申报 ↗ |
| 2026-02-25 | Fonseca Lidia | 代扣税 (F) | Common Stock | 55,124 | USD 26.92 | USD 1,484,118 | SEC 申报 ↗ |
| 2026-02-25 | DAMICO JENNIFER B. | 期权行权／转换 (M) | Common Stock | 17,558 | USD 33.82 | USD 593,812 | SEC 申报 ↗ |
| 2026-02-25 | DAMICO JENNIFER B. | 代扣税 (F) | Common Stock | 17,048 | USD 26.92 | USD 458,994 | SEC 申报 ↗ |
| 2026-02-25 | BOURLA ALBERT | 期权行权／转换 (M) | Common Stock | 491,626 | USD 33.82 | USD 16,626,791 | SEC 申报 ↗ |
| 2026-02-25 | BOURLA ALBERT | 代扣税 (F) | Common Stock | 475,544 | USD 26.92 | USD 12,803,056 | SEC 申报 ↗ |
| 2026-02-25 | BOSHOFF CHRISTOFFEL | 代扣税 (F) | Common Stock | 6,833 | USD 27.09 | USD 185,106 | SEC 申报 ↗ |
| 2026-02-25 | BOSHOFF CHRISTOFFEL | 奖励／授予 (A) | Common Stock | 13,383 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-23 | DAMICO JENNIFER B. | 代扣税 (F) | Common Stock | 419 | USD 27.06 | USD 11,338 | SEC 申报 ↗ |
| 2026-02-23 | BOSHOFF CHRISTOFFEL | 代扣税 (F) | Common Stock | 816 | USD 27.06 | USD 22,081 | SEC 申报 ↗ |
| 2026-01-30 | BOSHOFF CHRISTOFFEL | 代扣税 (F) | Common Stock | 12,887 | USD 26.44 | USD 340,732 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PFE |
| CIK | 0000078003 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—General Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 527 transaction lines from 2020-01-30 to 2026-08-12 15 P purchase lines · 96 S sale lines · 416 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.